Rapid Drug Desensitization: A Major Breakthrough for CFTR Modulators Hypersensitivity in Cystic Fibrosis Care
Received Date: Nov 05, 2024 / Published Date: Dec 05, 2024
Abstract
Cystic Fibrosis (CF) patients significantly benefit from Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies that have dramatically changed the course of this disease. However, hypersensitivity reactions, such as severe skin rashes, can threaten treatment continuity. Rapid desensitization protocols provide a promising approach to safely reintroduce these critical medications, always assessing the individuality of each case. By minimizing delays and interruptions with traditional, slower desensitization methods, these protocols optimize patient outcomes and quality of life, reinforcing their role as a valuable strategy in the management of CF patients who face allergic reactions to indispensable therapies.
Keywords: Cystic Fibrosis (CF); Drug; Hypersensitivity; Treatment
Citation: Rodríguez-Otero N (2024) Rapid Drug Desensitization: A Major Breakthrough for CFTR Modulators Hypersensitivity in Cystic Fibrosis Care. J Infect Dis Ther 12:610. Doi: 10.4173/2332-0877.1000610
Copyright: © 2024 Rodríguez-Otero N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open 91桃色 Journals
Article Tools
Article Usage
- Total views: 267
- [From(publication date): 0-0 - May 03, 2025]
- Breakdown by view type
- HTML page views: 94
- PDF downloads: 173
